Do We Have Enough Evidence to Implement Particle Therapy as Standard Treatment in Lung Cancer? A Systematic Literature Review

Keyphrases

• Lung Cancer 100%
• Systematic Literature Review 100%
• Particle Therapy 100%
• Proton 50%
• Survival Rate 50%
• 5-year Survival 50%
• Local Tumor Control 50%
• Tumor Control Rate 50%
• Cause-specific Survival 50%
• Heavy Charged Particles 50%
• High Incidence 25%
• Radiotherapy 25%
• Phase II Trial 25%
• Cost-effectiveness 25%
• Clinical Evidence 25%
• Non-small Cell Lung Cancer (NSCLC) 25%
• Carbon Ions 25%
• Proton Therapy 25%
• Societal Burden 25%
• Carbon Ion Radiotherapy 25%
• Hypofractionation 25%
• Oncologists 25%
• Clinical Costs 25%
• Photon Beam 25%
• Charged Particle Therapy 25%
• High Lethality 25%
• Radiation Pneumonitis 25%
• Hypofractionated Radiation 25%
• Lack of Evidence 25%

INIS

• lungs 100%
• cancer 100%
• therapy 100%
• reviews 100%
• particles 100%
• protons 50%
• charged particles 50%
• tumors 33%
• control 33%
• radiations 33%
• carbon ions 33%
• pneumonitis 16%
• patients 16%
• comparative evaluations 16%
• cost 16%
• efficiency 16%
• radiotherapy 16%
• beams 16%
• range 16%
• medical personnel 16%
• implementation 16%
• schedules 16%
• lung cells 16%
• fractionated irradiation 16%
• ion therapy 16%
• photon beams 16%

Medicine and Dentistry

• Systematic Review 100%
• Lung Cancer 100%
• Particle Therapy 100%
• Neoplasm 40%
• Overall Survival 40%
• Survival Rate 40%
• Cause Specific Survival 40%
• Health Care Cost 20%
• Non Small Cell Lung Cancer 20%
• Oncologist 20%
• Proton Therapy 20%
• Ion Therapy 20%
• Lethality 20%
• Hypofractionated Radiation 20%
• Radiation Therapy 20%
• Phase III Trials 20%